Market Closed -
Other stock markets
|
After market 19:00:10 | |||
3.64 USD | -3.96% | 3.58 | -1.65% |
05-28 | RBC Halves Price Target on Verastem to $16 From $32, Maintains Outperform Rating, Speculative Risk Qualifier | MT |
05-24 | Top Midday Decliners | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
92.19M | - | - | - | - | - | |
125B | ||||||
108B | ||||||
24.57B | - | |||||
22.82B | - | |||||
18.19B |
- Stock Market
- Equities
- VSTM Stock
- Charts Verastem, Inc.
- Sector Chart